Clesrovimab is an extended half-life RSV neutralizing antibody in development for all infants in their first RSV season and ...

Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some ...

Shawn Johnson shares daughter Drew Hazel, 4, and sons Jett James, 2, and Barrett 'Bear' Madison, 10 months, with her husband ...

RSV is a virus that can make people sick, especially older adults and babies. But even though RSV can be serious, people aren ...

There has been a surge in cases of a deadly virus with more babies admitted to hospital, according to the UK Health Security ...

WellSpan Ephrata Community Hospital is now offering respiratory syncytial virus immunizations to infants born at the hospital ...

Respiratory syncytial virus (RSV) season has begun in our area, and we are already seeing babies being hospitalized. RSV is a ...

Health experts highlight how this highly contagious disease affects vulnerable populations and share insights on prevention ...

Merck's (MRK) monoclonal antibody clesrovimab shows cuts RSV infections by 60% in infants, with a strong safety profile. Read ...

Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing ...